gnipst bulletin 50.1

16-10-2015

GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 22200011155516th October, 2015 Volume No.: 50 Issue No.: 01

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE

BASED LEARNING AND PRACTICE

Contents Message from PRINCIPAL Editorial board Historical article News Update Knowledge based Article Disease Related Breaking

News Upcoming Events Drugs Update Campus News Students Section Editors Note Archive

GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

Website: http://gnipst.ac.in

National Seminer on Current Innovation in Biotechnology for Human Welfare, 7th November, 2015 at GNIPST

16-10-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen. But it can't happen if you quit." Lauren Dane. We are what we repeatedly do. Excellence then is not an act, but a habit. Aristotle It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last years editors and congratulate the newly selected editors for the current year. Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement. I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students. It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead. The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students. The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students. I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination. Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path. My best wishes to all. Dr. A. Sengupta

Click here to go at the top

1

1

16-10-2015

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

Aage Bohr (1922 2009) Early Life and Education

Aage Niels Bohr was born in Denmarks capital city, Copenhagen, on June 19, 1922.

In the same year as Aage was born, his father, Niels Bohr, was awarded the Nobel Prize in Physics for his explanation of the structure of atoms and the radiation emitted by them.

Aages mother, Margrethe Nrlund, gave birth to six children all boys; Aage was the fourth. Margrethe was well educated; she assisted Niels Bohr with his paperwork and discussed his scientific research with him in detail.

Aage Bohrs education was both conventional and, from a scientific point of view, extraordinarily privileged. Like many other students of high school age in Copenhagen, he attended grammar school the Sortedam Gymnasium. Unlikeother students, he also enjoyed conversations with some of the worlds most outstanding physicists, including his father, of course.

In later life Aage recalled some of the giants of science who had worked in Copenhagen with his father; he met them so regularly that they became his uncles including Uncle Werner Heisenberg (Nobel Prize in Physics 1932) and Uncle Wolfgang Pauli (Nobel Prize in Physics 1945).


2

2

16-10-2015

Aage Bohrs Scientific Work Like his father, Aage Bohr was intrigued by the structure of the atom. The atomic nucleus in particular; that tiny, densely packed, positively charged mass at the heart of every atom interested him intensely. What was the nucleus really like were there any structural details, and if so, what were they? The Nucleus as a Drop of Liquid One idea, which had been developed most fully by Niels Bohr and John Archibald Wheeler in the late 1930s, was the liquid-drop model. The liquid-drop model pictured the nucleus as a rotating drop of incompressible liquid held together by surface tension. The drop of liquid could be deformed from its basic spherical shape and a large drop of liquid could fall apart to form two new drops. Similarly a large atomic nucleus, like uranium, could fall apart to form two new atomic nuclei this is nuclear fission, the energy source behind both the uranium atom bomb and the uranium power plant. The liquid drop model had its greatest successes in explaining the properties of heavy nuclei, such as uranium. By 1950, however, the liquid drop model was in danger of being pushed aside by the newer shell model of the nucleus. The Nucleus with Energy Shells Much like electrons are said to occupy shells of different energy outside the nucleus, the shell model of the nucleus says protons and neutrons occupy distinct energy shells inside the nucleus. By 1950, most physicists had decided the shell model looked more promising than the liquid-drop model. In particular, the shell model explained why atomic nuclei with so-called magic numbers of protons+neutrons are particularly stable. This is similar to the concept taught in high school chemistry, where atoms with complete electron shells, for example, 2 or 8


3

3

16-10-2015

electrons in their outermost shells are particularly stable, leading to the unreactive behavior of the noble gases. In the case of atomic nuclei, the magic numbers of 2, 8, 20, 28, 50, 82 and 126 protons+neutrons result in particularly stable nuclei. The shell model was particularly good at explaining the properties of lighter nuclei and nuclei with the magic numbers of protons+neutrons, but was less successful with heavy nuclei such as uranium. Unification In fact, the liquid-drop model and the shell model both had advantages and disadvantages indicating that neither could be the full story. In 1949, James Rainwater, a Columbia University physicist, decided to combine the best aspects of the liquid-drop and shell models into a single unified model of the nucleus. At that time Rainwater shared an office at Columbia with Bohr and explained his ideas to him. Bohr was captivated, seeing the potential of Rainwaters ideas to explain the behavior and structure of the atomic nucleus. Bohr returned to Copenhagen, determined to pursue the unified model further. There he worked with Ben Mottelson, who had completed his Ph.D. at Harvard University and who was now in Copenhagen on a Traveling Fellowship from Harvard. Together, Bohr and Mottelson worked out in intricate detail how a unified model could explain a huge number of experimental observations from different atomic nuclei. In 1953 they published a 173-page report describing their unified model and in 1954 Bohr published The Rotational States of Atomic Nuclei. Crucially, predictions they made about how nuclei would behave were verified in experiments. One of their key findings was that some of the behavior of nuclei could be explained by nuclei having different amounts of energy resulting from rotation. Furthermore, nuclei do not rotate as rigid objects but, instead, a surface wave travels around the nucleus.


4

4

16-10-2015

They also found that nuclei vibrate, changing their shape around an average value. At first Bohr had trouble convincing his father that the liquid-drop model should be dropped after all, Niels Bohr was one of the liquid-drop models main architects but eventually he won his father round. The unified model often called the collective model is sometimes likened to a swarm of bees, where each bee is a neutron or proton and the swarm is the nucleus. The swarm acts as a single entity, even though each bee within it is moving around independently with its own, individual energy. In the Bohr-Mottelson model, the outside of the swarm rotates and wobbles inward and outward. Each neutron or proton has its own orbital energy within the nucleus. These orbits can sometimes deform the nucleus so that it is no longer truly spherical. For example, the nucleus of heavier atoms can become an oblate spheroid (discus shaped) or prolate spheroid (football shaped). Of course, we need to remember that atomic nuclei have a diameter of between 1.7 x 1015 m for hydrogen and about 15 x 1015 m for uranium. The fact that Bohr and others were able to mathematically model such incredibly small objects, producing fine structural detail, and predicting their behavior in agreement with experimental data is remarkable. In 1975, Aage Bohr, Ben Mottelson and James Rainwater shared the Nobel Prize in Physics for their model of the nucleus. In the words of the award committee, the prize was: for the discovery of the connection between collective motion and particle motion in atomic nuclei and the development of the theory of the structure of the atomic nucleus based on this connection. Despite the huge strides taken by the trio of physicists, even today, the structural details of atomic nuclei have still not been fully resolved.


5

5

16-10-2015

The End Aage Bohr died on September 8, 2009, aged 87. He was buried in the Mariebjerg Cemetery, Copenhagen. His first wife, Marietta, died in 1978. Bohr was survived by his second wife, Bente Meyer Scharff, whom he had married in 1981, and by two sons and a daughter from his marriage to Marietta. One of his sons, Tomas, became a Professor of Physics at the Technical University of Denmark.

NEWS UPDATE For children with rare genetic disorder, more

extensive epilepsy surgery yields better seizure control: (15th October, 2015) Children with the genetic disorder tuberous sclerosis complex (TSC) often need epilepsy surgery for severe, uncontrollable seizures. A new study finds that seizure control is improved for patients undergoing more extensive surgery.

Researchers link organ transplant drug to rise in rare lymphoma: (15th October, 2015)

The immunosuppressive drug mycophenolate mofetil (MMF) has been linked by a researcher to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients, suggests a new report.

Developing tools to find new generation antibiotics: (15th October, 2015)

Scientists have taken an important step in the search to find new antibiotics that are effective against resistant bacteria. The work, scientists say, will provide new tools for creating stable genetically engineered strains which could lead to improvements to existing antibiotics and the development of new ones.


6

6

16-10-2015

Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries: (15th October, 2015)

New research highlights the scale and profile of cancer in indigenous peoples of the USA, Canada, Australia and New Zealand, revealing high rates of often preventable cancers including lung and cervical cancer, emphasizing the need for targeted prevention strategies in these populations.

Decoding the microbial signature of aggressive form of breast cancer: (15th October, 2015)

Researchers have identified, for the first time, an association between two microbial signatures and triple negative breast cancer, the most aggressive form of the disease.

Gene signature may help predict survival outcomes for some children with rhabdomyosarcoma: (15th October, 2015)

Among children with intermediate-risk rhabdomyosarcoma that is negative for a fusion gene, those who had a high score of a specific gene signature called MG5 had poorer survival outcomes compared with those who had a low score of MG5, report researchers.

Proteins play key role in genes that help auditory hair cells grow: (15th October, 2015)

Right now, there is no way to reverse hearing loss, largely because auditory hair cells, which sense sound and relay that information to the brain, do not regenerate. A new study, however, has found a key clue to how these hair cells develop. The study identified a new role for a particular group of proteins in the development and survival of the hair cells.


7

7

16-10-2015

Laser-based imaging tool could increase accuracy, safety of brain tumor surgery: (14th October, 2015)

Researchers are testing technology that gives brain surgeons real-time microscopic vision of tumors, potentially allowing the surgical decision-making process to become data driven, instead of subjective "best guesses," say authors of a new report.

Four in ten older adults burdened by demands of health care system: (13th October, 2015)

Nearly four in ten older adults say that managing their health care needs is difficult for them or their families, that medical appointments or tests get delayed or dont get done, or that all of the requirements of their health care are too much to handle, new research suggests.

Both red and white wine can improve sugar control depending on genetic profile: (13th October, 2015)

In this first two year long alcohol study, researchers aimed to assess the effects and safety of initiating moderate alcohol consumption in diabetics, and sought to determine whether the type of wine matters. They gradually initiated moderate wine consumption, as part of a healthy diet platform, and not before driving. The trial completed with unprecedented adherence rate of 87 percent after two years. For detail mail to editor


8

8

16-10-2015

KNOWLEDGE BASED ARTICLE

FDA expands approved use of Opdivo in advanced lung cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy. Lung cancer is the leading cause of cancer death in the United States, with an estimated 221,200 new diagnoses and 158,040 deaths in 2015. The most common type of lung cancer, non-small cell lung cancer (NSCLC), is further divided into two main types named for the kinds of cells found in the cancer squamous cell and non-squamous cell (which includes adenocarcinoma).Opdivo works by targeting the cellular pathway known as PD-1/PD-L1 (proteins found on the bodys immune cells and some cancer cells). By blocking this pathway, Opdivo may help the bodys immune system fight the cancer cells. Earlier this year, the FDA approved Opdivoto treat patients with advanced squamous NSCLC whose disease progressed during or after platinum-based chemotherapy. Todays approval expands the use of Opdivo to also treat patients with non-squamous NSCLC. There is still a lot to learn about the PD-1/PD-L1 pathway and its effects in lung cancer, as well as other tumor types, said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDAs Center for Drug Evaluation and Research. While Opdivo showed an overall survival benefit in certain non-small cell lung cancer patients, it appears that higher expression of PD-L1 in a patients tumor predicts those most likely to benefit. The safety and effectiveness of Opdivo for this use was demonstrated in an international, open-label, randomized study of 582 participants with advanced NSCLC whose disease progressed during or after treatment with platinum-based chemotherapy and appropriate biologic therapy. Participants were treated with


9

9

16-10-2015

Opdivo or docetaxel. The primary endpoint was overall survival, and the secondary endpoint was objective response rate (the percentage of patients who experienced complete or partial shrinkage of their tumors). Those treated with Opdivo lived an average of 12.2 months compared to 9.4 months in those treated with docetaxel. Additionally, 19 percent of those treated with Opdivo experienced a complete or partial shrinkage of their tumors, an effect that lasted an average of 17 months, compared to 12 percent among those taking docetaxel, which lasted an average of six months. While patients who received Opdivo lived longer than those who received docetaxel across the study, an evaluation of samples from a subgroup of patients tumors suggests that the level of PD-L1 expression in NSCLC tumors may help identify patients who are more likely to live longer due to treatment with Opdivo. Therefore, today the FDA also approved the PD-L1 IHC 28-8 pharmDx test to detect PD-L1 protein expression levels and help physicians determine which patients may benefit most from treatment with Opdivo. The most common side effects of Opdivo are fatigue, musculoskeletal pain, decreased appetite, cough and constipation. Opdivo also has the potential to cause serious side effects that result from the immune system effect of Opdivo (known as immune-mediated side effects). These severe immune-mediated side effects involve healthy organs, including the lung, colon, liver, kidneys, hormone-producing glands and the brain. The FDA granted Opdivo breakthrough therapy designation for this indication based on preliminary clinical evidence that suggested Opdivo may offer a substantial improvement over available therapies. It also received priority review status, which is granted to drugs that, at the time the application was submitted, have the potential to be a significant improvement in safety or effectiveness in the treatment of a serious condition. The approval of Opdivo occurred approximately three months ahead of the prescription drug user fee goal date of January 2, 2016, the date


10

10

16-10-2015

when the agency was scheduled to complete its review of the application. Another drug called Keytruda (pembrolizumab), manufactured by Merck, also targets the PD-1/PD-L1 pathway and was granted accelerated approval last weekfor treating NSCLC specifically for patients whose tumors expressed PD-L1. Opdivo is marketed by Bristol-Myers Squibb based in Princeton, New Jersey. ThePD-L1 IHC 28-8 pharmDx test is marketed by Dako North America Inc. in Carpinteria, California. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nations food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. Jeenatara Begum Assistant Professor GNIPST

DISEASE RELATED BREAKING NEWS Circulating vaccine-derived poliovirus Lao

Peoples Democratic Republic: (12th October, 2015) On 8 October 2015, the National IHR Focal Point of the Lao Peoples Democratic Republic (PDR) notified WHO of one confirmed type 1 vaccine-derived poliovirus (VDPV) case. Read more


11

11

16-10-2015

UPCOMING EVENTS 3rd International Conference and Exhibition on Pharmacognosy,

Phytochemistry & Natural Products will be held on 26th to 28th October, 2015 at Hydrabad.

DRUGS UPDATES Acetaminophen Tablets by Medline Industries:

Recall - Mislabeling with Incorrect Strength: (15th October, 2015) On October 9, 2015, Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot # 45810 of Acetaminophen tablets, 500mg, uncoated compressed tablets to the consumer level. The Acetaminophen 500mg, Tab 100/BT (OTC20101) has been found to be mislabeled displaying Acetaminophen 325mg (OTC10101) instead of Acetaminophen 500mg. The Acetaminophen tablets, 500mg is incorrectly labeled as 325 mg tablets. This error is not easily identifiable by the user or prescriber. If the product is taken at the maximum labeled dose, every four hours, five doses a day, or with other medications containing acetaminophen, it may lead to liver toxicity or liver failure.

Read more CAMPUS NEWS National Science Day 2015:

On 7th November 2015, GNIPST is going to organize National Seminer on Current Innovation in Biotechnology for Human Welfare, a one Day Programme on Science for Nation Building Sponsored by West Bengal State Council of Science & Technology, Catalysed & Supported by National Council for Science, Technology & communication, DST, New Delhi.


12

12

16-10-2015

Name of the committees are given below:

Chief Patron: Sardar Jodh Singh

Patron: Mr Taranjit Singh

Advisor: Mr U. S. Mukherjee Prof Asit Guha

President: Dr Abhijit Sengupta

Convener : Dr Swati Chakraboty

Organizing Committee:

Chairman: Dr Swati Chakraboty

Co-Chairman: Dr Lopamudra Dutta

Organizing Secretary: Dr Asis Bala

Joint Secretary: Dr Prerona Saha

Tresurer: Sumana Roy

Scientific Committee:

Chairman: Dr Sumana Chatterjee

Co-Chairpersons: Debabroto Ghosh Dostidar

Reception & Hospitality Committee:

Chairman: Jaydip Roy

Co-Chairpersons: Sanchari Bhattacharya, Debasruti Ganguly,Dr

Utsav Debnath

Souvinior Committee:

Chairman: Dr Sriparna Kundu Sen

Co-Chairpersons: Jeenatara Begum, Sourav Pal

Registration Committee:


13

13

16-10-2015

Chairman: Samrat Bose

Co-Chairpersons: Prapti Chakraborty, Moumita Chakraborty

Food & Refreshment Committee: Chairman: Dipanjan Mandal

Co-Chairpersons: Soumya Bhattacharya , Tanmay Majumder

Publicity & Invitation Committee: Chairman: Tamalika

Chakraborty

Co-Chairpersons: Dr Aparupa Bhattacharya, Dr Kirat Ganguly, Dr

Bhaskar Choudhuri, Abhishek Chatterjee

Decoration Committee: Chairman: Anuranjita Kundu

Co-Chairpersons: Dr Koushik Sen, Sampat Kundu

Name of the Student members for different Committees are:

B.Pharm 4th year:

Anirban Roy

Subhadeep Das

Aishika Datta

Puja Adhikari

Maitryee Banerjee

Sreya Sanyal

Nilotpal Gorai

Subham Ghoshal

Suprabhat Bhattacharjee

Abhinandan Mondal

Tanmoy Das Biswas

Arijit Mondal


14

14

16-10-2015

Chandrika Saha

Swaranjit Banik

Sourav Saha

B.Sc 1st year:

Meghna Sur

Shivangi Pandey

Shivangi Choudhury

Vaishali Kacchalia

Sonali Thakkur

Simona Basak

Abhishek Chakroborty

Adrija Bhattacharjee

Chandrayee Sil

Somoduity Paul

Rishav Biswas

Solanki Sanu

P.Meghna Rao

Nimisha Choudhury

Indrila Mukherjee

Piu Bhattacharjee

Rudra Sen

Sayantani Guha

Avik Saha

Raj Adhya


15

15

16-10-2015

Sudeshna Chaterjee

Ankan Bhowmik

Ritwika Sur

Debleena Sil

Sayantan Sarkar

Nilanjan Roy

Anamika Ghosh

Srayan Biswas

B.Sc 2nd year:

Ritobroto Paul

Soumik Majumder

Sikha Jain

Varsha Srivastab

Riyanka Majumder

Protim Singha Roy

Nilabja Seel

Vishal Kumar Singh

Ankita Aditya

B.Sc 3rd year:

Imtiaz Mahamud

Bipasha Ray

Ankita Roy

Camellia Roy

Sreejita Roy


16

16

16-10-2015

BHM 1st year:

Mayuri Ghosh

Debottri Das

Sunanda Sarkar

BHM 2nd year:

Debashruti Roy

Srikant Kumar

BHM 3rd year:

Subham Chakraborty

Satabdi Bhattacharya

For the National Seminar on Current Innovation in Biotechnology for Human Welfare on 7th November 2015, last date for Abstract submission for poster presentation is 28th October 2015.

Winners of Intracollege Football Tournament: Congratulations to B.Pharm final year for their victory in Intracollege Football Tournament. Intracollege Football Tournament:

On 9th October and 10th October, 2015 GNIPST has organized the Intracollege Football Tournament.

EN BIOLET: On 5th and 6th October, 2015 seminar was held on EN-BIOLET by Stone India Ltd.


17

17

16-10-2015

INDOOR BATTLE 2015 On 24th September, 2015 GNIPST organised the Indoor games (Table Tennis, Carrom, Chess for both Boys and Girls) Indoor Battle 2015. Congratulations to all winners and participants. The Winners are: Table Tennis (for Boys): 1st: Soumen Dhara (M.Pharm, 2nd year [Pharmacology]) 2nd: Ratul Banduri (B.Pharm, 3rd year) 3rd: Sneham Sen (B.Pharm, 3rd year) Table Tennis (for Girls): 1st: Sweta Saha (B.Sc [BT], 3rd year) 2nd: Moutan Roy (B.Pharm, 2nd year) Carrom (for Boys): 1st: Sk. Sajjat Ali (B.Pharm, 4th year) and Sk. Abdul Aslam (B.Pharm, 3rd year) 2nd: Sourabh Saha (B.Pharm, 4th year) and Rajib Singha Roy (B.Pharm, 4th year) 3rd: Arnab Banerjee (M.Pharm, 2nd year [Pharmaceutics]) and Achinta Banerjee (M.Pharm, 2nd year [Pharmaceutics]) Carrom (for Girls): 1st: Sreyashee Mitra (B.Pharm 4th year) and Rituparna Das (B.Pharm 4th year) 2nd: Rinita DasBhowmik (B.H.M, 1st year) and Tania Datta (B.H.M, 1st year) 3rd: Sushmita Sen (D.Pharm, 2nd year) and Keya Das (D.Pharm, 2nd year) Chess (for Boys): 1st: Sayantan Dutta (B.Pharm, 3rd year) 2nd: Tanmoy Das Biswas (B.Pharm 4th year) 3rd: Sourabh Saha (B.Pharm 4th year)


18

18

16-10-2015

Chess (for Girls): 1st: Rituparna Das (B.Pharm 4th year) 2nd: Suchetana Dutta (B.Pharm 4th year) 3rd: Krishnakali Basu (B.Pharm 4th year) SAGAR DUTTA MEDICAL COLLEGE FEST-ASTERICA 2015

WINNER: The students of GNIPST stood first in the FASHION SHOW competition of Sagar Dutta Medical College Fest: Congratulation to the participants- Souvik Ganguly (B.H.M 2nd year) Riya Taran (B.Pharm 4th year) Moktar Hossain (B.Pharm 4th year) Chandrika Saha (B.Pharm 4th year) Swaranjeet Banik (B.Pharm 4th year) Sampita Pal (B.Pharm 3rd year) Ranit Kundu (M.Pharm 1st year) Susmita Kar (B.Pharm 2nd year) Md. Nadeem Shah (B.Pharm 4th year) Sreyashee Mitra (B.Pharm 4th year) Sunanda (M.Pharm 1st year) Best Male Model of ASTERICA 2k15: Souvik Ganguly (B.H.M 2nd year) Best Female Model of ASTERICA 2k15: Sampita Pal (B.Pharm 3rd year) Anchor: Sreejita Roy (B.Sc ) Solo Singing competition: Sayantan Goswami (B.Pharm 4th year):winner Arpita (B.Sc) :2nd runner up

CARNIVAL OF CANVASS: On 4th September the Students of GNIPST celebrated the freshers party for Masters degree students. On 4th September the students of GNIPST celebrated Teachers Day.


19

19

16-10-2015

ESPERANZA:

On 21st August, 2015 the 1st year students of GNIPST were welcomed in the Freshers Welcome Programme ESPERANZA.

HOMAGE TO FORMER PRESIDENT DR A P J ABDUL KALAM: On 31st July, 2015 all the students and teachers of GNIPST paid their homage for our former president Dr. A P J Abdul Kalam. ALUMNI ASSOCIATION:

GNIPST has been certified by the Alumni Association under the West Bengal Societies Registration Act, 1961. FAREWELL PROGRAMME:

On 15th May 2015 GNIPST celebrated the farewell programme Sesh Chithi for the final year students of M.Pharm, M.Sc, B.Pharm, B.Sc and BHM. JIS SAMMAN 2015

On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015. JIS SAMMAN Awards: Best College (Non Engineering):

GNIPST Best Principal:

Dr (Prof.) Avijit Sengupta Best HOD:

Mr. Jaydip Ray Best Faculty:

Mr. Debabrata Ghoshdastidar (Pharmacy) Dr. Swati Chakraborty (Life Sciences)

Best faculty since inception: Mr. Jaydip Ray

Best Office Staff: Ms. Jaya Banerjee

Best technical Assistant: Mr. Somnath Majhi


20

20

16-10-2015

College Blue: Avik Paul

Highest DGPA of 2014: B.Pharm: Purbali Chakraborty (4th year) Diksha Kumari (3rd year) Aishika Dutta (2nd year) Sampita Paul (1st year) M.Pharm: Aritra Mukherjee (Pharmaceutical Chemistry) Mounomukhar Bhattacharya (Pharmacology) B.Sc (Biotechnology): Papiya Saha (3rd year) Shomasree Das (2nd year) Ayanita Basak (1st year) B.Sc (Microbiology): Bonhisikha Chatterjee (3rd year) Riaz Hossain (2nd year) Soumi Chowdhury (1st year) BHM: Bishal Roy (3rd year) Shreyabhanja Chowdhury (2nd year) Recitation:

Udita Majumder Debate:

Srijita Roy Poushali Ganguly Quiz:

Arani Ray Dipayan Nath Band:

Syantan Ghoswami Anurag Ghosh


21

21

16-10-2015

Atanu Mondal Arka Khamaru Ritobroto Paul Abhirup Dasgupta

Fashion: Md. Nadeem Shah Koustav Sarkar Shaksar Saha Avirup Dasgupta Ranit Kundu Namrata Ganguly Shreyasee Mitra Chandrika Saha Debopriya Chatterjee Riya Taran

Innovative Modeling: Ankit Chowdhury Kartik Koley Mudasar Manna Dipan Chaterjee Abhishek Singh Kaustav Pal Manojit Dutta SPIRIT JIS 2015

On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015. GPAT 2015 Result:

The following B.Pharm. final year students have qualified, GPAT-2015. We congratulate them all. Diksha Kumari Rupanjay Bhattacharya Avik Paul Xtasy 2015: GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th March, 2015 to 1st April, 2015.


22

22

16-10-2015

FINISHING SCHOOL TRAINING PROGRAMME:

The FINISHING SCHOOL TRAINING PROGRAMME was organized by the Entrepreneurship Development Cell and Training & Placement Cell, GNIPST in collaboration with Indian Pharmacy Graduates Association (IPGA), Bengal Branch from 21st February to 11th April, 2015 at GNIPST Auditorium. On 21

st February, 2015 the Finishing School Training Programme of

GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy Director, Drug Control Office, Goutam Kr. Sen, President, IPGA, Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr. Ranendra Chakraborty, Sales Manager and Associate Director Dr. Reddys Laboratory. On 28th February, 2015 Dr. D. Roy, Former Deputy Drug Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager, Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning & Development, Cipla delivered their valuable lectures in the 2nd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager, QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager, Operation, Ranbaxy Laboratory Limited delivered their valuable lectures in the 3rd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President (Quality Assurance), Albert David Ltd. delivered his valuable lectures in the 4th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur University and presently associated with NIPER delivered his valuable lectures in the 5th FINISHING SCHOOL TRAINING PROGRAMME of GNIPST. On 11th April, 2015 the closing ceremony of the FINISHING SCHOOL TRAINING PROGRAMME was held in GNIPST Auditorium.


23

23

16-10-2015

JOBS: All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted on 23rd May, 2015 by Standard Pharmaceuticals Ltd. GSK for post: Production, QA, QC. All the students of Final Year B. Pharm and M. Pharm are hereby informed that an interview will be conducted by GSK for sales and marketing job. Details given below:

Date: 27.03.2015 Time: 09:45 am Venue : GSK Consumer Healthcare Limited, Unit No. 208,

2nd Floor, Ecospace Campus B (3 B), New Town, Rajarhat, 24 Pgs (N). Kolkata-700156.

THYROCARE provisionally selected 15 students from JIS Group. Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc Biotechnology have been selected. Ipsita Mondal (M. Sc Biotechnology) Debriti Paul (M. Sc Biotechnology) Debopriya Chatterjee {B. Sc (H) Biotechnology}

The final year students of B.Pharm (31 students) and B.Sc (11 students) attended the pooled campus drive of Abbott India Ltd. on 10th March, 2015 at Jadavpur University. Among them 17 students have gone through to the final round of this pooled campus drive and short listed for final selection.

ACHIEVEMENT: Congratulations to Anurag Chanda, student of B.Pharm final year

who have got the 1st prize in poster presentation event in Prakriti 2015 at Department of Agricultural and Food engineering, IIT, Kharagpur.

OTHERS: On 24th and 25th February, 2015 Swamiji of Gourio Math was delivered some motivational lectuers in GNIPST. The students of GNIPST participated in the 4th Sardar Jodh SinghTrophy organised by NIT on 20th February, 2015.


24

24

16-10-2015

On 8th February, 2015 Gnipst celebrated the Reunion programmeReminiscence Reloaded 2015.

STUDENTS SECTION WHO CAN ANSWER FIRST????

Answer of Previous Issues Questions: Artemisinin

Identify the person

Answer of Previous Issues Image:

Tu Youyou and Lou Zhicen

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at [email protected]

EDITORS NOTE

It is a great pleasure for me to publish the 1st issue of 50th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account GNIPST bulletin I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director


25

25

16-10-2015

of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue. ARCHIVE

The general body meeting of APTI, Bengal Branch has been conducted at GNIPST on 15th June, 2012. The program started with a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural Products, JU on the skill to write a good manuscript for publication in impact journals. It was followed by nearly two hour long discussion among more than thirty participants on different aspects of pharmacy education. Five nonmember participants applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for conducting the two years post graduate course (M.Pharm) in PHARMACOLOGY. The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to 120.

AICTE has sanctioned a release of grant under Research Promotion Scheme (RPS) during the financial year 2012-13to GNIPST as per the details below: a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical Science & Technology. b. Principal Investigator: Dr. LopamudraDutta. c. Grant-in-aid sanctioned:Rs. 16,25000/- only


26

26

16-10-2015

d. Approved duration: 3 years e. Title of the project: Screening and identification of potential medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants.

Activity Clubs of GNIPST: Name of Club Member Faculty SPORTS Mr. Debabrata GhoshDastidar LITERARY AND PAINTING Ms. Jeenatara Begum SCIENCE AND INNOVATIVE MODELLING

Mr. Samrat Bose

ECO Ms. Sumana Roy SOCIAL SERVICES Dr. Asis Bala PHOTOGRAPHY Ms. Sanchari Bhattacharya CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya


27

27

Aage Bohr (1922 2009)Early Life and EducationAage Bohrs Scientific WorkThe Nucleus as a Drop of LiquidThe Nucleus with Energy ShellsUnificationThe End

For children with rare genetic disorder, more extensive epilepsy surgery yields better seizure control: (15th October, 2015)Children with the genetic disorder tuberous sclerosis complex (TSC) often need epilepsy surgery for severe, uncontrollable seizures. A new study finds that seizure control is improved for patients undergoing more extensive surgery. Researchers link organ transplant drug to rise in rare lymphoma: (15th October, 2015)The immunosuppressive drug mycophenolate mofetil (MMF) has been linked by a researcher to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients, suggests a new report. Developing tools to find new generation antibiotics: (15th October, 2015)Scientists have taken an important step in the search to find new antibiotics that are effective against resistant bacteria. The work, scientists say, will provide new tools for creating stable genetically engineered strains which could lead to improv... Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries: (15th October, 2015)New research highlights the scale and profile of cancer in indigenous peoples of the USA, Canada, Australia and New Zealand, revealing high rates of often preventable cancers including lung and cervical cancer, emphasizing the need for targeted preven... Decoding the microbial signature of aggressive form of breast cancer: (15th October, 2015)Researchers have identified, for the first time, an association between two microbial signatures and triple negative breast cancer, the most aggressive form of the disease. Gene signature may help predict survival outcomes for some children with rhabdomyosarcoma: (15th October, 2015)Among children with intermediate-risk rhabdomyosarcoma that is negative for a fusion gene, those who had a high score of a specific gene signature called MG5 had poorer survival outcomes compared with those who had a low score of MG5, report researchers. Proteins play key role in genes that help auditory hair cells grow: (15th October, 2015)Right now, there is no way to reverse hearing loss, largely because auditory hair cells, which sense sound and relay that information to the brain, do not regenerate. A new study, however, has found a key clue to how these hair cells develop. The stud... Laser-based imaging tool could increase accuracy, safety of brain tumor surgery: (14th October, 2015)Researchers are testing technology that gives brain surgeons real-time microscopic vision of tumors, potentially allowing the surgical decision-making process to become data driven, instead of subjective "best guesses," say authors of a new report. Four in ten older adults burdened by demands of health care system: (13th October, 2015)Nearly four in ten older adults say that managing their health care needs is difficult for them or their families, that medical appointments or tests get delayed or dont get done, or that all of the requirements of their health care are too much to h... Both red and white wine can improve sugar control depending on genetic profile: (13th October, 2015)

In this first two year long alcohol study, researchers aimed to assess the effects and safety of initiating moderate alcohol consumption in diabetics, and sought to determine whether the type of wine matters. They gradually initiated moderate wine con...For detail mail to editor

KNOWLEDGE BASED ARTICLEFDA expands approved use of Opdivo in advanced lung cancer Circulating vaccine-derived poliovirus Lao Peoples Democratic Republic: (12th October, 2015)On 8 October 2015, the National IHR Focal Point of the Lao Peoples Democratic Republic (PDR) notified WHO of one confirmed type 1 vaccine-derived poliovirus (VDPV) case.Read more Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength: (15th October, 2015)

On October 9, 2015, Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot # 45810 of Acetaminophen tablets, 500mg, uncoated compressed tablets to the consumer level. The Acetaminophen 500mg, Tab 100/BT (OTC20101... CAMPUS NEWS STUDENTS SECTION

gnipst bulletin 50.1

Documents